Suite 8220
Philadelphia, PA 19107
(215) 955-8244
(215) 923-9387 fax
Most Recent Peer-reviewed Publications
- Immunoglobulin therapy and thrombosis: Coincidence or causation?
- RhIG for the treatment of immune thrombocytopenia: Consensus and controversy (CME)
- Systematic criteria for type and screen based on procedure's probability of erythrocyte transfusion
- Platelet refractoriness in acquired hemophagocytic syndrome
- Transfection of human platelets with short interfering RNA
Medical School
MD, Harvard Medical School - 1977
BA, Emory University, Humanities
- 1973
Board Certification
Board Certification, American Board of Pediatrics, Pediatric Hematology/Oncology, 1987
Board Certification, American Board of Pediatrics, Pediatrics, 1981
Special Qualification, American Board of Pathology, Blood Banking, 1990
University Appointment
Professor
Director, Blood Bank, Transfusion Medicine, Therapeutic Apheresis and Blood Donation Program
Research and Clinical Interests
Dr. Jay H. Herman is the Director of Transfusion Medicine for Thomas Jefferson Hospital, which includes the Blood Bank and Transfusion Service, Therapeutic Apheresis and our own Blood Donor Program. He graduated from Harvard Medical School, and had post-graduate training in Pediatrics, Pediatric Hematology/Oncology, Adult Hematology, Clinical Pathology and Transfusion Medicine/Blood Banking. His interests have focused in the fields of platelet transfusion practice, platelet transfusion refractoriness, platelet and neutrophil serology, antigen characterization and identification, pediatric/neonatal transfusion, immunohematologic complications of stem cell transplantation, new apheresis technology and most recently hypotensive transfusion reactions. Dr. Herman is a nationally prominent expert in Transfusion Medicine and was recruited by the American Association of Blood Banks to develop and edit books on Platelet Transfusion Therapy and Platelet Alloimmunity and Pediatric Transfusion Therapy.
Platelet refractoriness;
Platelet and granulocyte serology;
Neonatal alliommune disorders;
Post-transplantation immune cytopenias;
Platelet transfusion therapy;
Pediatric/neonatal transfusion;
Stem cell collection and processing.
